top of page
  • Reuters Health, Andrew M. Seaman

Cancer drugs may remain approved despite lack of benefit

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found.

Read the full article here.

9 views0 comments

Recent Posts

See All
bottom of page